Centro de Pesquisas Gonçalo Moniz (CPqGM), Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Bahia, Brazil.
Malar J. 2010 Jan 13;9:13. doi: 10.1186/1475-2875-9-13.
Despite clinical descriptions of severe vivax malaria cases having been reported, data regarding immunological and inflammatory patterns are scarce. In this report, the inflammatory and immunological status of both mild and severe vivax malaria cases are compared in order to explore immunopathological events in this disease.
Active and passive malaria case detections were performed during 2007 in Buritis, Rondônia, in the Brazilian Amazon. A total of 219 participants enrolled the study. Study individuals were classified according to the presence of Plasmodium vivax infection within four groups: non-infected (n = 90), asymptomatic (n = 60), mild (n = 50) and severe vivax infection (n = 19). A diagnosis of malaria was made by microscopy and molecular assays. Since at present no clear criteria define severe vivax malaria, this study adapted the consensual criteria from falciparum malaria. Patients with severe P. vivax infection were younger, had lived for shorter time in the endemic area, and recalled having experienced less previous malaria episodes than individuals with no malaria infection and with mild or asymptomatic infection. Strong linear trends were identified regarding increasing plasma levels of C reactive protein (CRP), serum creatinine, bilirubins and the graduation of disease severity. Plasma levels of tumour necrosis factor (TNF), interferon-gamma(IFN-gamma) and also IFN-gamma/interleukin-10 ratios were increased and exhibited a linear trend with gradual augmentation of disease severity. Both laboratory parameters of organ dysfunction and inflammatory cytokines were reduced during anti-parasite therapy in those patients with severe disease.
Different clinical presentations of vivax malaria infection present strong association with activation of pro-inflammatory responses and cytokine imbalance. These findings are of utmost importance to improve current knowledge about physiopathological concepts of this serious widespread disease.
尽管已经有关于重症间日疟病例的临床描述报告,但关于免疫和炎症模式的数据仍然缺乏。在本报告中,比较了轻症和重症间日疟病例的炎症和免疫状态,以探讨该疾病中的免疫病理事件。
2007 年在巴西亚马逊的朗多尼亚州的布里蒂斯进行了主动和被动疟疾病例检测。共有 219 名参与者入组了该研究。根据是否存在间日疟原虫感染,将研究个体分为四组:未感染(n=90)、无症状(n=60)、轻症(n=50)和重症间日疟感染(n=19)。通过显微镜和分子检测进行疟疾诊断。由于目前尚无明确的标准来定义重症间日疟,本研究采用了来自恶性疟的共识标准。重症间日疟感染的患者更年轻,在流行地区的居住时间更短,且与未感染疟疾和患有轻症或无症状感染的个体相比,他们回忆起经历的疟疾发作次数更少。随着疾病严重程度的增加,血浆 C 反应蛋白(CRP)、血清肌酐、胆红素水平呈明显线性趋势升高。肿瘤坏死因子(TNF)、干扰素-γ(IFN-γ)和 IFN-γ/白细胞介素-10 比值的血浆水平升高,并呈线性趋势,随着疾病严重程度的逐渐增加而升高。在那些患有重症疾病的患者中,在寄生虫治疗期间,器官功能障碍的实验室参数和炎症细胞因子均有所降低。
不同临床表现的间日疟感染与促炎反应的激活和细胞因子失衡密切相关。这些发现对改善对这种广泛流行疾病的病理生理概念的现有认识至关重要。